CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 330 target
Drug / intervention
Euro D +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02434380
NCT02434380Phase 3Completed

Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes: a Randomized Controlled Trial in Pregnant Women With Hypovitaminosis D

American University of Beirut Medical Center·interventional·Posted May 5, 2015·Updated Mar 20, 2023

In Brief

A Phase 3 clinical trial evaluating Euro D for Hypovitaminosis D and 2 related conditions. Completed, enrolled 330 participants across 1 site.

Detailed Summary

The optimal vitamin D replacement dose during pregnancy remains undefined. Therefore, the aim of this study is to test the hypothesis that a daily equivalent dose of vitamin D of 3,000 IU/day is needed for Middle Eastern women, to optimize maternal vitamin D level and neonatal musculoskeletal parameters, specifically knee-heel length at birth and bone mineral content at one month of age.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesLebanon

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 5, 2015
Enrollment StartJul 1, 2015
Primary CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 11.2 years ago

Interventions

Euro Ddietary

Vitamin D3 Euro D 10,000 IU (1 tablet) plus Euro D Placebo (1 tablet) weekly, alternating with Euro D Placebo (2 tablets) weekly, starting at the second trimester and continued until delivery.

Euro Ddietary

Vitamin D3 Euro D 10,000 IU (2 tablets, equivalent to 20,000 IU) weekly, starting at the second trimester and continued until delivery.